| Literature DB >> 36077690 |
Weronika Misiąg1, Anna Piszczyk1, Anna Szymańska-Chabowska2, Mariusz Chabowski3,4.
Abstract
In 2020, 19.3 million new cancer cases were diagnosed, and almost 10 million deaths from cancer were recorded. Cancer patients may experience fatigue, depression, anxiety, reduced quality of life and sleep problems. Cancer treatments cause numerous side effects and have a negative impact on all body systems. Physical activity is important for cancer patients. The aim of this review is to analyse recent studies on the role of physical activity in cancer patients and emphasize its importance. The review included 36 papers published in English between 2017 and 2021. The findings from these studies show that physical activity decreases the severity of side effects of cancer treatment, reduces fatigue, improves quality of life, has a positive impact on mental health and improves aerobic fitness in cancer patients. Moreover, it reduces the risk of cancer recurrence and death. Physical activity is recommended for patients with any type of cancer and at all stages of treatment. The type of physical activity should depend on the condition of the individual patient. It is extremely difficult to determine what type, intensity and duration of physical activity is likely to have the greatest effect.Entities:
Keywords: cancer care; physical activity; quality of life; survivors
Year: 2022 PMID: 36077690 PMCID: PMC9454950 DOI: 10.3390/cancers14174154
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575
Figure 1Identification of studies via databases.
Comparison of the influence of physical activity on cancer survivors.
| Author (Ref.) | Type of Cancer, Number of | Intervention Type, | Frequency, Duration | Main Findings |
|---|---|---|---|---|
| Singh B. et al. [ | colorectal cancer ( | supervised and unsupervised aerobic and combined exercise | pre-treatment supervised: 1 session per week, unsupervised: 3–7 times per week for 4 weeks; during chemotherapy and post-treatment: from 1 to 7 sessions per week for 7 days to 6 months. | Superior to UC for: QoL, aerobic fitness, sleep, fatigue, reduced body fat, depression, upper-body strength ( |
| An K-Y. et al. [ | breast cancer ( | CARE | 25–30 min of aerobic exercise ( | The “combined” group was superior for: fatigue, upper and lower body endurance, body fat percentage—12-month follow up, CARE after chemotherapy may be optimal for longer-term health outcomes |
| Cannioto R.A. et al. [ | breast cancer ( | DELCaP [ | from minimum PAGAs | 1 year after diagnosis: reduction in recurrence and mortality |
| Parker N.H. et al. | pancreatic cancer ( | aerobic exercise, full-body strengthening exercises | 60 min/week—moderate intensity aerobic PA; 60 min/week of strengthening exercises, 7–25 weeks | Exercise recommendations for cancer survivors are important, but in order to reduce barriers to participation, further efforts are needed. |
| Dieli- | breast cancer ( | combined aerobic and resistance exercise | 16 weeks, 150 min of aerobic exercise with 2–3 days of resistance exercise training/week | Superior to usual care for QoL, fatigue, depression, muscular strength ( |
| Li W et al. [ | childhood cancer ( | adventure-based training program: | 4 training days: 2 weeks, 2, 4, and 6 months after | Significantly lower levels of CRF ( |
| Jones T.L. et al. [ | ovarian cancer (20 articles with sample sizes from 10 to 7022) | aerobic | 3 to 26-week intervention, from 75 min/week to 225 min/week | Higher health-related QoL, decreased levels of anxiety and depression, improvement in fatigue, physical and psychological health |
| Galvao D. et al. [ | prostate cancer with bone metastases ( | resistance, aerobic, flexibility exercise | 3 times per week, 60 min session, for 3 months | After 3 months—improved self-reported physical function, muscle strength. No changes for total body fat mass, fatigue ( |
| Cataldi et al. [ | breast cancer ( | each session: cardiorespiratory, resistance, flexibility, postural education exercises | 8-week programme, 60 min of exercise, 2 days per week | Measures of fatigue have decreased ( |
| Di Maso et al. [ | prostate cancer ( | occupational and recreational physical activity and Mediterranean diet | 15-year follow-up | Intervention reduces mortality in PCa patients (due to lowering serum insulin levels, IGF and inflammation). |
| Wang et al. [ | non-metastatic prostate cancer ( | recreational physical activity, e.g., walking, bicycling, aerobics, dancing, jogging, tennis | MET-h/week < 3.5, 3.5–8.75, 8.75, ≤17.5, >17.5 | 37% lower risk of PCSM among men with lower-risk tumours (Gleason score 2–7, T1–T2, |
| Dieli-Conwright C.M. et al. [ | overweight and obese survivors of breast cancer ( | aerobic, resistance exercise | 3 times per week for 16 weeks | Improved levels of insulin, IGF-1, leptin, adiponectin, BMI, skeletal mass index. At 3-month follow-up, all variables remained improved. |
| Tubiana-Mathieu N. et al. [ | breast cancer ( | CPET, 6MWT- 6-min walk test | 6 min | 6MWT allows for the calculation of the required exercise intensity |
| Watson G.A. et al. [ | Colorectal cancer ( | aerobic and resistance training | 150 min of moderate intensity aerobic exercise in 3–5 sessions per week; resistance training—at least 2 days per week for 6–12 weeks | PA: reduces mortality and risk of recurrence in cancer survivors; improves QoL, allows maintaining a healthy weight, decreases fatigue. |
| Rogers L.Q. et al. | breast cancer ( | BEAT Cancer—physical activity behaviour change intervention | PA recommendations from American Cancer Society, 12 supervised exercise sessions for the first 6 weeks, then unsupervised home-based exercises, >150 min/week of moderate to vigorous PA, 3- and 6-month follow-up | BEAT Cancer was superior to usual care for improvement in sleep quality ( |
PA—physical activity; CARE—Combined Aerobic and Resistance Exercise; DELCaP—Diet, Exercise, Lifestyle and Cancer Prognosis Study; PAGA—Physical Activity Guidelines for Americans; RPA—recreational physical activity; MET—metabolic equivalent of task (minutes/hours); PCa—prostate cancer; PCSM—prostate-cancer-specific mortality; CRF—cancer-related fatigue.
Figure 2A graphical abstract summarizing the presented results.